A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naïve metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.
The Advanced Mini Link System (AMLS) is a digital data link system formanned and unmanned platforms with a unique design suitable for mini and small UAS. Weighing only 300 gr - and suitable for long ...
CXCR4 is a negative prognostic marker in acute myeloid leukemias (AMLs). Therefore, it is necessary to develop novel ways to inhibit CXCR4 expression in leukemia. AMD3100 is an inhibitor of CXCR4 ...
It has been shown that individual acute myeloid leukemia (AML) patients are characterized by one of few initiating DNA mutations and 5–10 cooperating mutations not yet defined among hundreds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback